Organon (OGN) Pension (2023 - 2024)
Organon (OGN) posted quarterly Pension of $77.0 million for Q4 2024, up 1.32% year-over-year from $76.0 million in Q1 2024, and up 1.32% on a QoQ basis from $76.0 million in Q4 2023.
Organon (OGN) Pension (2023 - 2024) Analysis & Trends
Organon has reported Pension for 2 years, with the latest figure at $77.0 million in Q4 2024.
- Pension for Q4 2024 came in at $77.0 million, up 1.32% year-over-year; the trailing twelve-month figure through Dec 2024 was $77.0 million (up 1.32% YoY), and the FY2024 annual result was $77.0 million, up 1.32% from the prior year.
- Pension improved to $77.0 million in Q4 2024, from $76.0 million in the prior quarter.
- Over five years, Pension peaked at $77.0 million in Q4 2024 and troughed at $76.0 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn |
| 10 | Organon | 3.61 Bn | 2.47 Bn | 847.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 77.00 Mn |
| Dec 31, 2023 | 76.00 Mn |